===
EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of
financial statements
Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/interim
statements
2024-05-08 / 08:00 CET/CEST
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS
News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:
Report Type: Quarterly/ Interim statement within the 1st half-year
Language: German
Date of disclosure: May 15, 2024
Address: https://ir.dermapharm.de/de/investor-relations/#tagline-19857
Language: English
Date of disclosure: May 15, 2024
Address: https://ir.dermapharm.de/en/investor-relations/#tagline-19876
2024-05-08 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press
Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      Dermapharm Holding SE 

Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

End of News EQS News Service
===
1895309 2024-05-08 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1895309&application_name=news

END) Dow Jones Newswires

May 08, 2024 02:00 ET (06:00 GMT)